Lee Frank D. 4
4 · Bausch Health Companies Inc. · Filed May 20, 2026
Research Summary
AI-generated summary of this filing
Bausch Health (BHC) Director Lee Frank D. Sells 24,456 Shares
What Happened
- Lee Frank D., a director of Bausch Health Companies Inc. (BHC), sold 24,456 shares of BHC common stock on 2026-05-19 at $5.43 per share, generating proceeds of $132,796. This was a sale (not a purchase or option exercise).
Key Details
- Transaction date and price: 2026-05-19 at $5.43 per share.
- Total value: $132,796 (24,456 shares × $5.43).
- Transaction type: Sale (code S), executed in the open market.
- Footnote: The shares were sold pursuant to a Rule 10b5-1 trading plan to fund estimated tax obligations arising from a previously vested equity award granted to the issuer's non-employee directors.
- Shares owned after transaction: Not disclosed in the filing.
- Filing timeliness: Reported on 2026-05-20 (timely filing, one day after the transaction).
Context
- The sale was executed under a pre-established 10b5-1 plan, which allows insiders to sell shares at predetermined times and is commonly used to cover tax liabilities or diversify holdings. Such planned sales are routine and do not by themselves indicate a change in the insider’s view of the company.
Insider Transaction Report
Form 4
Lee Frank D.
Director
Transactions
- Sale
Common Shares, No Par Value
[F1]2026-05-19$5.43/sh−24,456$132,796→ 49,339 total
Footnotes (1)
- [F1]Represents shares of the Issuer's common stock, no par value, sold in the open market pursuant to a Rule 10b5-1 trading plan to fund estimated tax obligations arising from a previously vested equity award granted to the Issuer's non-employee directors.
Signature
/s/ Brianna M. Dorsi, attorney-in-fact|2026-05-20